Brief: Bioporto Q3 EBIT Loss Narrows To DKK 14.5 Mln

BioPorto A/S

17/11/2021 08:04

Nov 17 (Reuters) - Bioporto A/S  BIOPOR.CO :
    * BIOPORTO ANNOUNCES Q3 2021 REPORT
    * EXPECT TO REDUCE EBIT LOSS FOR 2021 FROM APPROXIMATELY DKK
73
MILLION TO NOW APPROXIMATELY DKK 63 MILLION.
    * REVISED EBIT GUIDANCE WILL HAVE A POSITIVE EFFECT ON
BIOPORTO'S
CASH POSITION END-2021 COMPARED TO PREVIOUS ESTIMATES
    * FOR FINANCIAL YEAR 2021, BIOPORTO ADJUST EXPECTATIONS FOR
REVENUE TO APPROXIMATELY DKK 24 MILLION FROM PREVIOUS GUIDANCE
OF DKK 30 MILLION.
    * EXPECTS TO HAVE FUNDING INTO Q3 2022 WHEREAS PREVIOUSLY
ESTIMATED TO Q2 2022.
    * Q3 REVENUE DKK 5.3 MILLION VERSUS DKK 4.7 MILLION YEAR AGO
    * COMPANY BASED ON CURRENT OUTLOOK EXPECTS TO HAVE FUNDING
INTO Q3
2022 WHEREAS PREVIOUSLY ESTIMATED TO Q2 2022
    * AS IN PREVIOUS QUARTERS, WE HAVE SEEN A SATISFYING
DEVELOPMENT
IN OUR ACTIVITIES IN Q3 2021
    * Q3 EBIT LOSS DKK  14.5 MILLION VERSUS LOSS DKK 17.7 
MILLION
YEAR AGO
    * Q3 NET FINANCIALS AT DKK 0.6 MILLION VERSUS LOSS DKK 1
MILLION
YEAR AGO

Source text for Eikon:  ID:nGNE4vKbwT 
Further company coverage:  BIOPOR.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))